Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.
Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Dario
D
Campana
Departments of Oncology and Pathology, St. Jude Children's Research Hospital, Memphis, TN; and.|Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN.
Ching-Hon
CH
Pui
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001215:Asparaginase / Q000008:administration & dosage; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D060828:Induction Chemotherapy; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D018365:Neoplasm, Residual; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood* / Q000188:drug therapy* / Q000473:pathology; D011239:Prednisolone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone; D001215:Asparaginase; D008727:Methotrexate; D003630:Daunorubicin